Thursday, January 27, 2011

Worldwide Market for In Vitro Diagnostic Tests, 7th Edition


Worldwide Market for In Vitro Diagnostic Tests, 7th Edition

Buy Now  : Market Research
In seven best-selling editions, Shara Rosen has provided a total view of every aspect of the market for in vitro diagnostic (IVD) testing in one complete volume. The report, The Worldwide Market for In Vitro Diagnostic Tests, stands as a testament to the Kalorama methodology. Real industry knowledge combined with an exhaustive review of the medical, business, and company literature. A discovery of the trends that are impacting the industry now, and a realistic forecast five years into the future for companies already participating in or considering entry into this growing industry. The idea behind Kalorama’s unique report is that the entire market can be captured in one volume and business planners can use it as a key reference. Published every two years, this volume includes all of the major segments of clinical lab testing, including:
  • Point of Care (POC), (Professional and Self-Testing)
  • Core Lab (General Chemistries, Workstations, Analyzers)
  • Immunoassays (Blood Gases, Urinalysis, Critical Care)
  • Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal)
  • Hematology
  • Coagulation (Lab-Based, POC, Genetic Markers)
  • Microbiology and Virology
  • Blood Banking (Grouping, Immunoassay Screens, NAT Screens)
  • Histology and Cytology (Pap, ISH, IHC, traditional non-pap, HPV)

Worldwide Market for In Vitro Diagnostic Tests, 7th Edition

For each of these sections, Shara Rosen reviews the key products dominating the market segment, the innovations that are occurring, trends that are impacting the segment. Market size, and forecast and market share are provided; and a geographic share of the segment is provided where possible. Changes in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Current market is provided for 2009; projections are made through 2014.
Kalorama Information’s Report – ‘The Bible of the IVD Industry’
Many of the top IVD companies use this product for business planning, which means that this volume can provide a uniform standard for in vitro diagnostic market numbers. These are the numbers that it is very likely competitive companies will be using in their planning.
This 800+ page edition greatly expands coverage of the field and tracks the most important developments. Expanded or added in this edition are sections on:
  • The Impact of US Health Care Reform
  • The Spread of Wireless Diagnostics
  • New Screening Guidelines and Market Impact
  • Chronic vs. Infectious Disease
  • Strange Bedfellows? An Update on the IVD Industry Consolidation
  • The Continued Molecularization of Devices
  • The Current Economic Situation: Recession: Post-Recession?
  • Non-Invasive Sampling
  • PGx and SNP Testing
  • The Dynamic Core Lab
  • IVD and the Promise of Personalized Medicine
  • Update on Regulation of Novel Devices
  • Focus on the Continued Fight against Nosocomial Infections
  • Where Molecular Diagnostics Stands Today
  • Innovations in Blood Banking
  • Companies on the Move, and Those in Decline
  • Histology/Cytology innovations; the role of FISH testing.
In addition, there are now profiles of established and emerging players in IVD, more than 200 companies, from the top tier to the dominant middle, to the companies to watch.

Related Reports

at